ISSN: 0198-6325

Journal Home

Journal Guideline

Medicinal Research Reviews Q1 Unclaimed

John Wiley and Sons Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Medicinal Research Reviews is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 130. It has a price of 2750 €. It has an SJR impact factor of 2,868 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,868.

Medicinal Research Reviews focuses its scope in these topics and keywords: advances, targeting, receptor, binding, cancer, drug, diversify, discoverynew, discovery, developments, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Drug Discovery (Q1) Molecular Medicine (Q1) Pharmacology (Q1)

Price

2750 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

2,868

SJR Impact factor

130

H Index

105

Total Docs (Last Year)

162

Total Docs (3 years)

22297

Total Refs

1985

Total Cites (3 years)

157

Citable Docs (3 years)

12,11

Cites/Doc (2 years)

212,35

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Reviews Drug Discovery Q1
Perspectives in Medicinal Chemistry Q1
Molecular Therapy Q1
Cell Chemical Biology Q1
Protein & Cell Q1

Compare this journals

Aims and Scope

Best articles by citations

Design of Hedgehog pathway inhibitors for cancer treatment

Progress in antisense therapeutics

Fas/FasL interaction: A novel immune therapy approach with immobilized biologicals

Genetics, Genomics, and Drug Discovery

Camptothecin and taxol: Discovery to clinic

Repurposing approved drugs on the pathway to novel therapies

Allosteric modulation of G protein-coupled receptors by amiloride and its derivatives. Perspectives for drug discovery?

Competitive AMPA receptor antagonists

Insights into the role of nitric oxide in inflammatory arthritis

Small molecular anti-cytokine agents

The Development of Delivery Agents that Facilitate the Oral Absorption of Macromolecular Drugs

ATP site-directed competitive and irreversible inhibitors of protein kinases

SHOW MORE ARTICLES

A systems approach to molecular structure, intermolecular recognition, and emergence-dissolvence in medicinal research

Hepcidin and its therapeutic potential in neurodegenerative disorders

Probes for the dopamine transporter: New leads toward a cocaine-abuse therapeutic?A focus on analogues of benztropine and rimcazole

PROfusion?: Genetically Tagged Proteins for Functional Proteomics and Beyond

ADP receptors on platelets and ADP-selective antiaggregating agents

Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition

Applications of Lewis acids for the efficient syntheses of diltiazem, cephems, and taxoids

Marine pyridoacridine alkaloids and synthetic analogues as antitumor agents

Leptin: An annotated addendum

Orexin supplementation in narcolepsy treatment: A review

Structure-affinity relationships of adenosine A2B receptor ligands

Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery